首页 > 最新文献

Urologia Journal最新文献

英文 中文
A thematic analysis of the perceptions of reversible inhibition of sperm under guidance as a potential family planning method in the United Kingdom. 对英国将指导下可逆性抑制精子作为一种潜在计划生育方法的看法的专题分析。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-26 DOI: 10.1177/03915603241261813
Cristina M Gheorghe, Olivia Slack, Amanda D Wilson

Background: This exploratory study aimed to look into public perceptions of Reversible Inhibition of Sperm Under Guidance (RISUG) as a family planning method in the United Kingdom (UK). It also aimed to discover if there were any sex differences in perceptions between males and females.

Design: Twelve semi-structured interviews were conducted, six with males and six with females, all residents of the UK.

Methods: The audio data from the interviews then was transcribed for analysis. An inductive and a semantic thematic analysis was conducted on the data set.

Results: Three main themes were constructed, including: (i) RISUG Hesitancy, (ii) Females perceived benefits of RISUG and (iii) Males perceived concerns regarding RISUG. Hesitancy was related to vaccination hesitancy, females wanted males to have more reproductive autonomy and males placed their concerns through the lens of 'other' males that their may be unintended side effects. Together these three themes represent both perceived risk and overall benefits of the method. However, while randomized control trails have been completed to standard for RISUG, males perceived concerns, suggesting a disconnect between the public's perceptions and professionals understanding of trails.

Conclusion: RISUG was perceived as a viable option for family planning in the future, however trust of the new contraceptive method will need to be fostered among the public in order to effectively transfer knowledge on the potential side effects and the standard of pre-market testing for these. Effective public health messages can result in better education of people concerning the new contraceptive method, including the risks and benefits. By using perceptions to inform health messages around RISUG, researchers and practitioners can learn from potential users how to best address misinformation or concerns, while at the same time building an evidence base for when new male methods reach the contraceptive market.

背景:这项探索性研究旨在调查英国(UK)公众对可逆性精子抑制指导法(RISUG)作为一种计划生育方法的看法。研究还旨在发现男性和女性在认识上是否存在性别差异:设计:进行了 12 次半结构式访谈,其中 6 次为男性访谈,6 次为女性访谈,访谈对象均为英国居民:然后对访谈的音频数据进行转录分析。对数据集进行了归纳和语义主题分析:结果:共构建了三个主题,包括:(i) RISUG 犹豫不决;(ii) 女性认为 RISUG 有益;(iii) 男性认为 RISUG 有忧。犹豫不决与疫苗接种犹豫不决有关,女性希望男性有更多的生育自主权,而男性则从 "其他 "男性的角度来考虑他们的担忧,即他们可能会有意想不到的副作用。这三个主题共同代表了该方法的可感知风险和总体益处。然而,尽管 RISUG 已完成了符合标准的随机对照试验,但男性仍有顾虑,这表明公众的看法与专业人员对试验的理解之间存在脱节:RISUG被认为是未来计划生育的一个可行选择,但还需要提高公众对这种新避孕方法的信任度,以便有效传播有关潜在副作用和上市前测试标准的知识。有效的公共卫生信息可以使人们更好地了解新的避孕方法,包括其风险和益处。研究人员和从业人员可以利用人们对 RISUG 的认知来传播健康信息,从而从潜在用户那里了解如何最有效地消除误导或担忧,同时为新的男性避孕方法进入避孕市场建立证据基础。
{"title":"A thematic analysis of the perceptions of reversible inhibition of sperm under guidance as a potential family planning method in the United Kingdom.","authors":"Cristina M Gheorghe, Olivia Slack, Amanda D Wilson","doi":"10.1177/03915603241261813","DOIUrl":"10.1177/03915603241261813","url":null,"abstract":"<p><strong>Background: </strong>This exploratory study aimed to look into public perceptions of Reversible Inhibition of Sperm Under Guidance (RISUG) as a family planning method in the United Kingdom (UK). It also aimed to discover if there were any sex differences in perceptions between males and females.</p><p><strong>Design: </strong>Twelve semi-structured interviews were conducted, six with males and six with females, all residents of the UK.</p><p><strong>Methods: </strong>The audio data from the interviews then was transcribed for analysis. An inductive and a semantic thematic analysis was conducted on the data set.</p><p><strong>Results: </strong>Three main themes were constructed, including: (i) RISUG Hesitancy, (ii) Females perceived benefits of RISUG and (iii) Males perceived concerns regarding RISUG. Hesitancy was related to vaccination hesitancy, females wanted males to have more reproductive autonomy and males placed their concerns through the lens of 'other' males that their may be unintended side effects. Together these three themes represent both perceived risk and overall benefits of the method. However, while randomized control trails have been completed to standard for RISUG, males perceived concerns, suggesting a disconnect between the public's perceptions and professionals understanding of trails.</p><p><strong>Conclusion: </strong>RISUG was perceived as a viable option for family planning in the future, however trust of the new contraceptive method will need to be fostered among the public in order to effectively transfer knowledge on the potential side effects and the standard of pre-market testing for these. Effective public health messages can result in better education of people concerning the new contraceptive method, including the risks and benefits. By using perceptions to inform health messages around RISUG, researchers and practitioners can learn from potential users how to best address misinformation or concerns, while at the same time building an evidence base for when new male methods reach the contraceptive market.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"819-823"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing safety and feasibility of monopolar transurethral resection of the prostate without post-operative catheter traction: A randomized controlled trial. 评估无术后导管牵引的单极经尿道前列腺切除术的安全性和可行性:随机对照试验。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-04-29 DOI: 10.1177/03915603241249227
Abhineeth Kp, Kumar Madhavan, Devashish Kaushal, Manoj Biswas, Sonu Kumar Plash, Viswas Mr

Introduction: Traction on the per-urethral catheter is commonly employed after monopolar transurethral resection of the prostate (mTURP) to reduce bleeding. However, its efficacy and impact on postoperative pain remain uncertain. Further, there is limited evidence to suggest any benefit regarding post-operative blood loss.

Materials and methods: In a randomized controlled trial, 62 patients undergoing mTURP were assigned to either a traction (n = 30) or non-traction (n = 32) group. Blood loss, postoperative pain, and analgesic requirements were assessed between January 2022 and April 2023. {(IHEC-PGR/2021/DM/M.Ch/Jan/02), CTRI Registration: CTRI/2022/01/039199.}.

Results: No significant differences were observed between the traction and non-traction groups regarding postoperative blood loss (p-value- 0.632), fall in hemoglobin (p-value- 0.719) and hematocrit (p-value- 0.937) levels, and length of postoperative hospital stay (p-value- 0.797). However, the traction group reported significantly higher postoperative pain scores (p-value < 0.001) and increased analgesic requirements (p-value < 0.001).

Conclusion: The study suggests that 12-hours catheter traction after mTURP does not reduce blood loss and is associated with increased postoperative pain.

导言:单极经尿道前列腺切除术(mTURP)后通常会使用牵引尿道导管来减少出血。然而,其疗效和对术后疼痛的影响仍不确定。此外,关于术后失血的益处的证据也很有限:在一项随机对照试验中,62 名接受 mTURP 的患者被分配到牵引组(30 人)或非牵引组(32 人)。2022 年 1 月至 2023 年 4 月期间,对失血量、术后疼痛和镇痛需求进行了评估。{(IHEC-PGR/2021/DM/M.Ch/Jan/02),CTRI 注册:CTRI/2022/01/039199.}.Results:结果:牵引组和非牵引组在术后失血量(p 值- 0.632)、血红蛋白(p 值- 0.719)和血细胞比容(p 值- 0.937)水平下降以及术后住院时间(p 值- 0.797)方面无明显差异。然而,牵引组的术后疼痛评分明显更高(p 值 p 值 结论:研究表明,经皮直肠癌根治术后 12 小时的导管牵引并不能减少失血量,而且会增加术后疼痛。
{"title":"Assessing safety and feasibility of monopolar transurethral resection of the prostate without post-operative catheter traction: A randomized controlled trial.","authors":"Abhineeth Kp, Kumar Madhavan, Devashish Kaushal, Manoj Biswas, Sonu Kumar Plash, Viswas Mr","doi":"10.1177/03915603241249227","DOIUrl":"10.1177/03915603241249227","url":null,"abstract":"<p><strong>Introduction: </strong>Traction on the per-urethral catheter is commonly employed after monopolar transurethral resection of the prostate (mTURP) to reduce bleeding. However, its efficacy and impact on postoperative pain remain uncertain. Further, there is limited evidence to suggest any benefit regarding post-operative blood loss.</p><p><strong>Materials and methods: </strong>In a randomized controlled trial, 62 patients undergoing mTURP were assigned to either a traction (<i>n</i> = 30) or non-traction (<i>n</i> = 32) group. Blood loss, postoperative pain, and analgesic requirements were assessed between January 2022 and April 2023. {(IHEC-PGR/2021/DM/M.Ch/Jan/02), CTRI Registration: CTRI/2022/01/039199.}.</p><p><strong>Results: </strong>No significant differences were observed between the traction and non-traction groups regarding postoperative blood loss (<i>p</i>-value- 0.632), fall in hemoglobin (<i>p</i>-value- 0.719) and hematocrit (<i>p</i>-value- 0.937) levels, and length of postoperative hospital stay (<i>p</i>-value- 0.797). However, the traction group reported significantly higher postoperative pain scores (<i>p</i>-value < 0.001) and increased analgesic requirements (<i>p</i>-value < 0.001).</p><p><strong>Conclusion: </strong>The study suggests that 12-hours catheter traction after mTURP does not reduce blood loss and is associated with increased postoperative pain.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"709-714"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140858097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial. 胆钙化醇和水飞蓟素改善良性前列腺增生症下尿路症状的疗效评估:一项双盲、随机对照试验。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-09-02 DOI: 10.1177/03915603241274467
Reza Valipour, Behzad Narouie, Hamidreza Momeni, Negar Radpour, Parham Torabinavid, Amirreza Momeni, Ali Jowzi

Introduction: Benign prostatic hyperplasia (BPH) mainly leads to lower urinary tract symptoms (LUTS) in aging men. The present study investigates the role of cholecalciferol, Silymarin, and their combined administration in patients with BPH suffering from LUTS.

Methods: This double-blind, randomized, controlled trial enrolled 80 participants (50-80 years) diagnosed with BPH, from March 2019 to March 2020. Based on serum 25-(OH) vitamin D levels we formed subgroups, each receiving specific interventions. Measurements of International Prostate Symptom Score (IPSS), Maximal Urinary Flow Rate (Q-max), Prostate Volume (PV), Post-Void Residual (PVR), and Prostate-Specific Antigen (PSA) were recorded at baseline and following 3 months of follow-up.

Results: Participants with serum concentration of 25-(OH) vitamin D below 20 ng/ml simultaneously received cholecalciferol and Silymarin that significantly improved IPSS, irritation, obstruction, PV, and PVR. In those with concentrations ⩾20 ng/ml, a single use of Silymarin significantly reduced IPSS, irritation, obstruction, and PVR. Adjustment of confounding variables revealed independent and significant effects of both cholecalciferol and Silymarin on PVR, IPSS, and obstruction. Cholecalciferol also improved irritation, while Silymarin reduced prostate volume. These findings highlight potential therapeutic benefits for BPH-associated LUTS, encouraging further exploration and clinical consideration.

Conclusions: In this investigation, combination therapy with cholecalciferol at 50,000 IU/w for 8 weeks and Silymarin at a dosage of 480 mg for 3 months resulted in a notable improvement in the IPSS score, PV, and PVR, as well as both irritative and obstructive symptoms. However, the total PSA and free PSA amounts did not reach a significant difference.

导言:良性前列腺增生症(BPH)主要导致老年男性出现下尿路症状(LUTS)。本研究探讨了胆钙化醇、水飞蓟素及其联合用药对患有下尿路症状的良性前列腺增生症患者的作用:这项双盲、随机对照试验于 2019 年 3 月至 2020 年 3 月期间招募了 80 名确诊为良性前列腺增生症的参与者(50-80 岁)。根据血清中 25-(OH) 维生素 D 的水平,我们划分了几个亚组,每个亚组接受特定的干预措施。在基线和3个月的随访中记录了国际前列腺症状评分(IPSS)、最大尿流率(Q-max)、前列腺体积(PV)、膀胱术后残余(PVR)和前列腺特异性抗原(PSA)的测量结果:血清中 25-(OH) 维生素 D 浓度低于 20 纳克/毫升的患者同时服用胆钙化醇和水飞蓟素后,IPSS、刺激性、梗阻、PV 和 PVR 均有明显改善。对于血清中 D 含量 ⩾20 纳克/毫升的患者,同时服用水飞蓟素可明显降低 IPSS、刺激性、阻塞性和 PVR。对混杂变量进行调整后发现,胆钙化醇和水飞蓟素对 PVR、IPSS 和梗阻均有独立且显著的影响。胆钙化醇还能改善刺激症状,而水飞蓟素则能减少前列腺体积。这些发现凸显了治疗良性前列腺增生相关性尿失禁的潜在疗效,值得进一步探讨和临床考虑:在这项研究中,使用胆钙化醇 50,000 IU/w 进行为期 8 周的联合治疗,以及使用水飞蓟素 480 毫克进行为期 3 个月的联合治疗,可显著改善 IPSS 评分、前列腺体积和前列腺容积,以及刺激性和梗阻性症状。然而,总 PSA 和游离 PSA 的含量并无显著差异。
{"title":"Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial.","authors":"Reza Valipour, Behzad Narouie, Hamidreza Momeni, Negar Radpour, Parham Torabinavid, Amirreza Momeni, Ali Jowzi","doi":"10.1177/03915603241274467","DOIUrl":"10.1177/03915603241274467","url":null,"abstract":"<p><strong>Introduction: </strong>Benign prostatic hyperplasia (BPH) mainly leads to lower urinary tract symptoms (LUTS) in aging men. The present study investigates the role of cholecalciferol, Silymarin, and their combined administration in patients with BPH suffering from LUTS.</p><p><strong>Methods: </strong>This double-blind, randomized, controlled trial enrolled 80 participants (50-80 years) diagnosed with BPH, from March 2019 to March 2020. Based on serum 25-(OH) vitamin D levels we formed subgroups, each receiving specific interventions. Measurements of International Prostate Symptom Score (IPSS), Maximal Urinary Flow Rate (Q-max), Prostate Volume (PV), Post-Void Residual (PVR), and Prostate-Specific Antigen (PSA) were recorded at baseline and following 3 months of follow-up.</p><p><strong>Results: </strong>Participants with serum concentration of 25-(OH) vitamin D below 20 ng/ml simultaneously received cholecalciferol and Silymarin that significantly improved IPSS, irritation, obstruction, PV, and PVR. In those with concentrations ⩾20 ng/ml, a single use of Silymarin significantly reduced IPSS, irritation, obstruction, and PVR. Adjustment of confounding variables revealed independent and significant effects of both cholecalciferol and Silymarin on PVR, IPSS, and obstruction. Cholecalciferol also improved irritation, while Silymarin reduced prostate volume. These findings highlight potential therapeutic benefits for BPH-associated LUTS, encouraging further exploration and clinical consideration.</p><p><strong>Conclusions: </strong>In this investigation, combination therapy with cholecalciferol at 50,000 IU/w for 8 weeks and Silymarin at a dosage of 480 mg for 3 months resulted in a notable improvement in the IPSS score, PV, and PVR, as well as both irritative and obstructive symptoms. However, the total PSA and free PSA amounts did not reach a significant difference.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"727-737"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saline cleansing can prevent infective complications after transrectal prostate biopsy: A randomized prospective study. 生理盐水清洗可预防经直肠前列腺活检术后感染并发症:一项随机前瞻性研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-30 DOI: 10.1177/03915603241273888
Taha Çetin, Mehmet Yiğit Yalçın, Mert Hamza Özbilen, Gürkan Cesur, Çağdaş Bildirici, Erkin Karaca, Mahmut Can Karabacak, Erkan Aravacık, Taylan Tığlı, Oğuz Tarhan, Mehmet Yoldaş, Hayal Boyacıoğlu, Serdar Çelik, Gökhan Koç

Purpose: To discern whether reduced infection rates were attributed to antiseptic solutions or mechanical rectal irrigation.

Patients and methods: After receiving ethical approval, the study included patients who underwent transrectal prostate biopsy due to elevated PSA or abnormal digital rectal examination findings, and prostate cancer under active surveillance, at Tepecik Training and Research Hospital between April 2022 and June 2023. Standard antibiotic prophylaxis was administered. Patients were randomized into three equal groups according to the rectal irrigation strategy.

Results: Overall complications occurred in 4%. Despite distinct cleaning agents, there was no significant difference in infection rates (p = 0.780) or fever incidence (p = 0.776). Pathological analyses revealed comparable outcomes (p = 0.764).

Conclusion: The study challenges the prevailing belief that antiseptic solutions are indispensable for infection prevention, as saline demonstrated similar efficacy. Limitations include data gaps from potential external hospital visits and absent rectal microorganism swab culture. While TRUS-PB remains the gold standard, this study suggests that mechanically cleansing the rectal mucosa with saline-a cost-effective, side-effect-free alternative-may be a viable infection prevention method, particularly beneficial for patients with antiseptic allergies. The findings prompt a reconsideration of the necessity of antiseptic solutions in TRUS-PB, offering an alternative approach to mitigate infectious complications.

目的:了解感染率的降低是否归因于消毒液或机械直肠冲洗:在获得伦理批准后,该研究纳入了2022年4月至2023年6月期间在特佩契克培训与研究医院因PSA升高或数字直肠检查结果异常而接受经直肠前列腺活检的前列腺癌患者。采用标准抗生素预防。根据直肠冲洗策略将患者随机分为三组:总并发症发生率为 4%。尽管采用了不同的清洗剂,但感染率(P = 0.780)或发热发生率(P = 0.776)并无显著差异。病理分析显示结果相当(p = 0.764):这项研究对普遍认为消毒液是预防感染不可或缺的药物这一观点提出了质疑,因为生理盐水也具有类似的疗效。研究的局限性包括潜在的外部医院就诊和直肠微生物拭子培养的缺失。虽然 TRUS-PB 仍是金标准,但本研究表明,用生理盐水机械清洗直肠粘膜--一种经济有效、无副作用的替代方法--可能是一种可行的感染预防方法,尤其对防腐剂过敏的患者有益。研究结果促使人们重新考虑在 TRUS-PB 中使用消毒溶液的必要性,为减轻感染并发症提供了另一种方法。
{"title":"Saline cleansing can prevent infective complications after transrectal prostate biopsy: A randomized prospective study.","authors":"Taha Çetin, Mehmet Yiğit Yalçın, Mert Hamza Özbilen, Gürkan Cesur, Çağdaş Bildirici, Erkin Karaca, Mahmut Can Karabacak, Erkan Aravacık, Taylan Tığlı, Oğuz Tarhan, Mehmet Yoldaş, Hayal Boyacıoğlu, Serdar Çelik, Gökhan Koç","doi":"10.1177/03915603241273888","DOIUrl":"10.1177/03915603241273888","url":null,"abstract":"<p><strong>Purpose: </strong>To discern whether reduced infection rates were attributed to antiseptic solutions or mechanical rectal irrigation.</p><p><strong>Patients and methods: </strong>After receiving ethical approval, the study included patients who underwent transrectal prostate biopsy due to elevated PSA or abnormal digital rectal examination findings, and prostate cancer under active surveillance, at Tepecik Training and Research Hospital between April 2022 and June 2023. Standard antibiotic prophylaxis was administered. Patients were randomized into three equal groups according to the rectal irrigation strategy.</p><p><strong>Results: </strong>Overall complications occurred in 4%. Despite distinct cleaning agents, there was no significant difference in infection rates (<i>p</i> = 0.780) or fever incidence (<i>p</i> = 0.776). Pathological analyses revealed comparable outcomes (<i>p</i> = 0.764).</p><p><strong>Conclusion: </strong>The study challenges the prevailing belief that antiseptic solutions are indispensable for infection prevention, as saline demonstrated similar efficacy. Limitations include data gaps from potential external hospital visits and absent rectal microorganism swab culture. While TRUS-PB remains the gold standard, this study suggests that mechanically cleansing the rectal mucosa with saline-a cost-effective, side-effect-free alternative-may be a viable infection prevention method, particularly beneficial for patients with antiseptic allergies. The findings prompt a reconsideration of the necessity of antiseptic solutions in TRUS-PB, offering an alternative approach to mitigate infectious complications.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"768-774"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Turkish validation of the chronic orchialgia symptom index and its association with the visual analog scale. 土耳其慢性睾丸痛症状指数及其与视觉模拟量表的关联验证。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-04-10 DOI: 10.1177/03915603241246669
Aykut Demirci, Fatih Hızlı, Halil Başar

Objective: To conduct a translation and validation study of the Chronic Orchialgia Symptom Index (COSI), which has 12 questions in three domains pain (P), sexual symptoms (SS), and quality of life (QoL), in the Turkish language.

Material and methods: The study included a total of 175 patients diagnosed with chronic scrotal content pain (CSCP) between January 2023 and January 2024. In addition to demographic data, the scores obtained on the COSI questionnaire and Visual Analog Scale (VAS) were recorded. Internal consistency was assessed using Cronbach alpha coefficients. Reliability was evaluated using the test-retest correlation method.

Results: The mean age of the patients was 37.2 ± 14.1 years and the median (IQR) duration of pain was 5.5 (9) months. The median total COSI score was determined as 13 (13) and the median subscores were 7 (7) for P, 1 (2) for SS, and 5 (6) for QoL. The test-retest correlation coefficient for each item was determined to be higher than r = 0.80 (p < 0.001). The Cronbach alpha values for the subscores were 0.80 for P, 0.71 for SS, and 0.80 for QoL. There was determined to be a statistically significant positive correlation between the VAS score and the COSI P, SS, QoL, and total scores (r: 0.63, p < 0.001; r = 0.32, p < 0.001; r = 0.56, p < 0.001; r = 0.59, p < 0.001, respectively). The optimal cutoff point of the COSI total score was determined to be 16.5 points (AUC:0.77, p < 0.001) for the determination of patients experiencing severe pain (⩾ 7.5) according to the VAS score.

Conclusion: The Turkish version of the COSI questionnaire is a valid, reliable, and repeatable questionnaire that can be used to evaluate the effects of symptom severity in patients with CSCP.

目的:对慢性睾丸痛症状指数(COSI)进行翻译和验证研究:用土耳其语对慢性睾丸炎症状指数(COSI)进行翻译和验证研究,该指数包括疼痛(P)、性症状(SS)和生活质量(QoL)三个领域的12个问题:研究共纳入了 175 名在 2023 年 1 月至 2024 年 1 月期间被诊断为慢性阴囊内容物疼痛(CSCP)的患者。除人口统计学数据外,还记录了 COSI 问卷和视觉模拟量表(VAS)的得分。内部一致性采用 Cronbach alpha 系数进行评估。结果显示,患者的平均年龄为 37 岁:患者的平均年龄为 37.2 ± 14.1 岁,疼痛持续时间的中位数(IQR)为 5.5(9)个月。COSI 总分的中位数为 13(13)分,P、SS 和 QoL 的中位数分别为 7(7)分、1(2)分和 5(6)分。每个项目的测试-重复相关系数均高于 r = 0.80(p r:0.63, p r = 0.32, p r = 0.56, p r = 0.59, p p 结论:土耳其版 COSI 问卷是一份有效、可靠、可重复的问卷,可用于评估 CSCP 患者症状严重程度的影响。
{"title":"Turkish validation of the chronic orchialgia symptom index and its association with the visual analog scale.","authors":"Aykut Demirci, Fatih Hızlı, Halil Başar","doi":"10.1177/03915603241246669","DOIUrl":"10.1177/03915603241246669","url":null,"abstract":"<p><strong>Objective: </strong>To conduct a translation and validation study of the Chronic Orchialgia Symptom Index (COSI), which has 12 questions in three domains pain (P), sexual symptoms (SS), and quality of life (QoL), in the Turkish language.</p><p><strong>Material and methods: </strong>The study included a total of 175 patients diagnosed with chronic scrotal content pain (CSCP) between January 2023 and January 2024. In addition to demographic data, the scores obtained on the COSI questionnaire and Visual Analog Scale (VAS) were recorded. Internal consistency was assessed using Cronbach alpha coefficients. Reliability was evaluated using the test-retest correlation method.</p><p><strong>Results: </strong>The mean age of the patients was 37.2 ± 14.1 years and the median (IQR) duration of pain was 5.5 (9) months. The median total COSI score was determined as 13 (13) and the median subscores were 7 (7) for P, 1 (2) for SS, and 5 (6) for QoL. The test-retest correlation coefficient for each item was determined to be higher than <i>r</i> = 0.80 (<i>p</i> < 0.001). The Cronbach alpha values for the subscores were 0.80 for P, 0.71 for SS, and 0.80 for QoL. There was determined to be a statistically significant positive correlation between the VAS score and the COSI P, SS, QoL, and total scores (<i>r</i>: 0.63, <i>p</i> < 0.001; <i>r</i> = 0.32, <i>p</i> < 0.001; <i>r</i> = 0.56, <i>p</i> < 0.001; <i>r</i> = 0.59, <i>p</i> < 0.001, respectively). The optimal cutoff point of the COSI total score was determined to be 16.5 points (AUC:0.77, <i>p</i> < 0.001) for the determination of patients experiencing severe pain (⩾ 7.5) according to the VAS score.</p><p><strong>Conclusion: </strong>The Turkish version of the COSI questionnaire is a valid, reliable, and repeatable questionnaire that can be used to evaluate the effects of symptom severity in patients with CSCP.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"788-793"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of alternative medicine and complimentary therapies in urologic disease: New horizons. 替代医学和辅助疗法在泌尿科疾病中的作用:新视野。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-24 DOI: 10.1177/03915603241258697
Francesco Pio Bizzarri, Marco Campetella, Mauro Ragonese, Eros Scarciglia, Pierluigi Russo, Filippo Marino, Giovanni Battista Filomena, Filippo Gavi, Francesco Rossi, Lorenzo D'Amico, Carlo Gandi, Nazario Foschi, Salvatore Marco Recupero, Emilio Sacco

The world of complementary and alternative medicine (CAM) encompasses a wide range of practices, treatments, and products that fall outside the realm of conventional (mainstream) medicine. The use of complementary and CAM has become increasingly popular in Western nations. People are turning to CAM for a variety of reasons, including managing chronic diseases, relieving symptoms of various conditions, and improving their overall health and well-being. There's a growing trend of people using and showing interest in complementary and alternative medicine therapies, especially in Western countries. CAM encompasses a wide range of treatments, some offering complete alternatives to conventional medicine, while others aim to complement existing medical approaches. Urologists should stay informed about CAM to guide their patients effectively to treat patients in a modern and personalized way. The aim of review is to analyze the scenario of complimentary and alternative medicine with a specific focus in the urological field.

补充和替代医学(CAM)世界涵盖了传统(主流)医学领域之外的各种实践、治疗方法和产品。在西方国家,使用补充和替代医学越来越流行。人们求助于 CAM 的原因多种多样,包括控制慢性疾病、缓解各种症状以及改善整体健康和福祉。人们对补充和替代医学疗法的使用和兴趣呈增长趋势,尤其是在西方国家。补充和替代医学疗法包括多种治疗方法,有些完全可以替代传统医学,有些则旨在补充现有的医疗方法。泌尿科医生应随时了解 CAM 的相关信息,以便有效地指导患者,以现代化和个性化的方式治疗患者。本综述旨在分析补充和替代医学的情况,并特别关注泌尿科领域。
{"title":"The role of alternative medicine and complimentary therapies in urologic disease: New horizons.","authors":"Francesco Pio Bizzarri, Marco Campetella, Mauro Ragonese, Eros Scarciglia, Pierluigi Russo, Filippo Marino, Giovanni Battista Filomena, Filippo Gavi, Francesco Rossi, Lorenzo D'Amico, Carlo Gandi, Nazario Foschi, Salvatore Marco Recupero, Emilio Sacco","doi":"10.1177/03915603241258697","DOIUrl":"10.1177/03915603241258697","url":null,"abstract":"<p><p>The world of complementary and alternative medicine (CAM) encompasses a wide range of practices, treatments, and products that fall outside the realm of conventional (mainstream) medicine. The use of complementary and CAM has become increasingly popular in Western nations. People are turning to CAM for a variety of reasons, including managing chronic diseases, relieving symptoms of various conditions, and improving their overall health and well-being. There's a growing trend of people using and showing interest in complementary and alternative medicine therapies, especially in Western countries. CAM encompasses a wide range of treatments, some offering complete alternatives to conventional medicine, while others aim to complement existing medical approaches. Urologists should stay informed about CAM to guide their patients effectively to treat patients in a modern and personalized way. The aim of review is to analyze the scenario of complimentary and alternative medicine with a specific focus in the urological field.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"641-646"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic bladder diverticulectomy with concurrent management of bladder outlet obstruction: A choice to consider. 同时治疗膀胱出口梗阻的机器人膀胱憩室切除术:一个值得考虑的选择。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-06-17 DOI: 10.1177/03915603241258107
Angelo Orsini, Alessio Digiacomo, Simone Ferretti, Flavia Tamborino, Martina Basconi, Rossella Cicchetti, Giulio Litterio, Guglielmo Dello Stritto, Gaetano Salzano, Michele Marchioni, Luigi Schips

Introduction: Acquired bladder diverticula (BD) are associated with bladder outlet obstruction. The aim of our study is to analyse the improvement in lower urinary tract symptoms (LUTS) in patients who underwent robot-assisted bladder diverticulectomy (RABD) combined with transurethral prostatectomy (TURP).

Material and methods: A prospectively single-centre, single surgeon cohort of four patients with posterolateral BD due to bladder outlet obstruction (BOO) undergoing RABD combined with TURP between 2018 and 2023 was analysed.

Results: Median age and maximum BD diameter were 73.5 years and 16 cm, respectively. All patients had severe LUTS and elevated postvoid residual (PVR). Preliminary uroflowmetry revealed bladder outlet obstruction with a median of maximum urine flow rate of 8.5 ml/s. The median operative time and blood loss were 212 min and 100 ml, respectively. No intraoperative complications were recorded. The median length of stay was 4 days. The International Prostate Symptom Score (IPSS) and PVR were compared between baseline, 1 month and 6 months after surgery. IPSS significantly decreased from 24 (IQR 24-25) preoperatively compared to the postoperative, at 1 month follow up 7 (IQR 6-8) (p < 0.0001). PVR significantly decreased too from 165 (IQR 150-187) to 35 ml (IQR 25-42) (p < 0.0001). In transitioning from the 1-month follow-up to the 6-month follow-up, no substantial statistical improvement was observed.

Conclusion: Concomitant performance of TURP with RABD is feasible and safe. Diverticulectomy in addiction at the endoscopic procedure should be discussed with patients who have obstructive lower urinary tract symptoms as viable alternative to single procedure individually performed.

简介:后天性膀胱憩室(BD)与膀胱出口梗阻有关:后天性膀胱憩室(BD)与膀胱出口梗阻有关。我们的研究旨在分析机器人辅助膀胱憩室切除术(RABD)联合经尿道前列腺切除术(TURP)对患者下尿路症状(LUTS)的改善情况:对2018年至2023年间接受RABD联合TURP手术的4例因膀胱出口梗阻(BOO)导致后外侧膀胱憩室的患者进行了前瞻性单中心、单外科医生队列分析:中位年龄和最大 BD 直径分别为 73.5 岁和 16 厘米。所有患者均有严重的尿失禁和排尿后残余物(PVR)升高。初步尿流测量显示膀胱出口梗阻,最大尿流率中位数为 8.5 毫升/秒。中位手术时间和失血量分别为 212 分钟和 100 毫升。无术中并发症记录。中位住院时间为 4 天。对基线、术后 1 个月和 6 个月的国际前列腺症状评分(IPSS)和 PVR 进行了比较。IPSS 从术前的 24(IQR 24-25)明显降低到术后的 7(IQR 6-8)(p p 结论:同时进行 TURP 和 RABD 是可行且安全的。应与有下尿路梗阻症状的患者讨论在内窥镜手术中进行憩室切除术,作为单独手术的可行替代方案。
{"title":"Robotic bladder diverticulectomy with concurrent management of bladder outlet obstruction: A choice to consider.","authors":"Angelo Orsini, Alessio Digiacomo, Simone Ferretti, Flavia Tamborino, Martina Basconi, Rossella Cicchetti, Giulio Litterio, Guglielmo Dello Stritto, Gaetano Salzano, Michele Marchioni, Luigi Schips","doi":"10.1177/03915603241258107","DOIUrl":"10.1177/03915603241258107","url":null,"abstract":"<p><strong>Introduction: </strong>Acquired bladder diverticula (BD) are associated with bladder outlet obstruction. The aim of our study is to analyse the improvement in lower urinary tract symptoms (LUTS) in patients who underwent robot-assisted bladder diverticulectomy (RABD) combined with transurethral prostatectomy (TURP).</p><p><strong>Material and methods: </strong>A prospectively single-centre, single surgeon cohort of four patients with posterolateral BD due to bladder outlet obstruction (BOO) undergoing RABD combined with TURP between 2018 and 2023 was analysed.</p><p><strong>Results: </strong>Median age and maximum BD diameter were 73.5 years and 16 cm, respectively. All patients had severe LUTS and elevated postvoid residual (PVR). Preliminary uroflowmetry revealed bladder outlet obstruction with a median of maximum urine flow rate of 8.5 ml/s. The median operative time and blood loss were 212 min and 100 ml, respectively. No intraoperative complications were recorded. The median length of stay was 4 days. The International Prostate Symptom Score (IPSS) and PVR were compared between baseline, 1 month and 6 months after surgery. IPSS significantly decreased from 24 (IQR 24-25) preoperatively compared to the postoperative, at 1 month follow up 7 (IQR 6-8) (<i>p</i> < 0.0001). PVR significantly decreased too from 165 (IQR 150-187) to 35 ml (IQR 25-42) (<i>p</i> < 0.0001). In transitioning from the 1-month follow-up to the 6-month follow-up, no substantial statistical improvement was observed.</p><p><strong>Conclusion: </strong>Concomitant performance of TURP with RABD is feasible and safe. Diverticulectomy in addiction at the endoscopic procedure should be discussed with patients who have obstructive lower urinary tract symptoms as viable alternative to single procedure individually performed.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"762-767"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testicular histopathology and follicular stimulating hormone to predict fertility in nonobstructive azoospermia. 用睾丸组织病理学和促卵泡激素预测非梗阻性无精子症患者的生育能力。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-04-29 DOI: 10.1177/03915603241249229
Faris Abushamma, Rami S Alazab, Mohammed Z Allouh, Rafeef Abu Shamleh, Rola Abu Alwafa, Ibrahim Ghalayini

Purpose: To examine the ability of testicular histopathology in Non-obstructive azoospermia (NOA) in predicting sperm retrieval rate (SR), sperm quality and assisted reproductive technology success.

Methods: A retrospective study recruited clinically diagnosed NOA patients between 2007 and 2015. Testicular biopsy and conventional sperm extraction (TESE) were done concomitantly. Correlation between pathological categories, SR rate, sperm quality and success of intracytoplasmic sperm injection (ICSI) was studied. FSH was measured as a predictor of fertility.

Results: One hundred eighteen patients were recruited. Histopathological classification was hypospermatogenesis (HS) 45 (38%), maturation arrest (MA) 22(19%), Sertoli cell only syndrome (SCOS) 34 (29%) and normal spermatogenesis (NS) 17 (14%). FSH value was above normal level in 34 (76%) of HS, 19 (86%) of MA, 32 (94%) of SCOS and 5 (29%) of NS. Positive SR was obtained in 108 (92%) patients. The highest SR rate was seen in NS group 100% and the lowest was in SCOS 26 (77%). The worst sperm quality was found in SCOS as type C represents 46%, followed by MA 40% and HS 24%. Patients had ICSI following TESE had variable success rate as success of ICSI was seen (9/15) for HS, (0/7) for MA, (5/15) for SCOS and (8/9) for NS. FSH is strongly correlated to SR, quality of sperm and success of ICSI as positive SR in normal FSH patients was obtained in 28 (100%) of normal FSH, 70 (97%) of high FSH and 10 (56%) of double high FSH (p value < 001). The success of ICSI significantly correlates with FSH value as normal FSH has 77% success ICSI rate, high FSH (52%) and double high FSH (0%) (p value < 0.001).

Conclusions: Testicular biopsy and histopathology findings in NOA are strongly correlated SR rate, quality of sperms, and success of ICSI. FSH is a strong noninvasive predictor of fertility in NOA patients.

目的:研究非梗阻性无精子症(NOA)患者睾丸组织病理学在预测取精率(SR)、精子质量和辅助生殖技术成功率方面的能力:一项回顾性研究招募了2007年至2015年间临床诊断为NOA的患者。睾丸活检和传统精子提取术(TESE)同时进行。研究了病理类别、SR率、精子质量和卵胞浆内单精子显微注射(ICSI)成功率之间的相关性。FSH是预测生育能力的指标:结果:共招募了 118 名患者。组织病理学分类为精子发生功能低下(HS)45 例(38%)、成熟停滞(MA)22 例(19%)、仅有绒毛细胞综合征(SCOS)34 例(29%)和精子发生正常(NS)17 例(14%)。34(76%)例 HS、19(86%)例 MA、32(94%)例 SCOS 和 5(29%)例 NS 的 FSH 值高于正常水平。108例(92%)患者的SR呈阳性。NS 组的 SR 率最高,为 100%;SCOS 组的 SR 率最低,为 26(77%)。SCOS 组的精子质量最差,C 型占 46%,其次是 MA 40%,HS 24%。TESE 后进行 ICSI 的患者成功率不一,HS 组为 9/15,MA 组为 0/7,SCOS 组为 5/15,NS 组为 8/9。FSH与SR、精子质量和卵胞浆内单精子显微注射成功率密切相关,正常FSH患者中有28例(100%)SR阳性,高FSH患者中有70例(97%)SR阳性,双高FSH患者中有10例(56%)SR阳性(P值 P值 结论):NOA患者的睾丸活检和组织病理学结果与SR率、精子质量和ICSI成功率密切相关。FSH是预测NOA患者生育能力的强有力的非侵入性指标。
{"title":"Testicular histopathology and follicular stimulating hormone to predict fertility in nonobstructive azoospermia.","authors":"Faris Abushamma, Rami S Alazab, Mohammed Z Allouh, Rafeef Abu Shamleh, Rola Abu Alwafa, Ibrahim Ghalayini","doi":"10.1177/03915603241249229","DOIUrl":"10.1177/03915603241249229","url":null,"abstract":"<p><strong>Purpose: </strong>To examine the ability of testicular histopathology in Non-obstructive azoospermia (NOA) in predicting sperm retrieval rate (SR), sperm quality and assisted reproductive technology success.</p><p><strong>Methods: </strong>A retrospective study recruited clinically diagnosed NOA patients between 2007 and 2015. Testicular biopsy and conventional sperm extraction (TESE) were done concomitantly. Correlation between pathological categories, SR rate, sperm quality and success of intracytoplasmic sperm injection (ICSI) was studied. FSH was measured as a predictor of fertility.</p><p><strong>Results: </strong>One hundred eighteen patients were recruited. Histopathological classification was hypospermatogenesis (HS) 45 (38%), maturation arrest (MA) 22(19%), Sertoli cell only syndrome (SCOS) 34 (29%) and normal spermatogenesis (NS) 17 (14%). FSH value was above normal level in 34 (76%) of HS, 19 (86%) of MA, 32 (94%) of SCOS and 5 (29%) of NS. Positive SR was obtained in 108 (92%) patients. The highest SR rate was seen in NS group 100% and the lowest was in SCOS 26 (77%). The worst sperm quality was found in SCOS as type C represents 46%, followed by MA 40% and HS 24%. Patients had ICSI following TESE had variable success rate as success of ICSI was seen (9/15) for HS, (0/7) for MA, (5/15) for SCOS and (8/9) for NS. FSH is strongly correlated to SR, quality of sperm and success of ICSI as positive SR in normal FSH patients was obtained in 28 (100%) of normal FSH, 70 (97%) of high FSH and 10 (56%) of double high FSH (<i>p</i> value < 001). The success of ICSI significantly correlates with FSH value as normal FSH has 77% success ICSI rate, high FSH (52%) and double high FSH (0%) (<i>p</i> value < 0.001).</p><p><strong>Conclusions: </strong>Testicular biopsy and histopathology findings in NOA are strongly correlated SR rate, quality of sperms, and success of ICSI. FSH is a strong noninvasive predictor of fertility in NOA patients.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"800-806"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semen parameter enhancement after varicocelectomy: Insights into varicose vein diameter and BMI influence: A cross-sectional study. 精索静脉曲张切除术后精液参数的提高:精索静脉直径和体重指数的影响:一项横断面研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-04-18 DOI: 10.1177/03915603241247290
Mohammad Kazem Hariri, Mohammad-Bagher Rajabalian, Behzad Narouie, Sina Ahmadaghayi, Ghasem Rostami, Khadijeh Ezoji, Hamidreza Momeni, Negar Radpour

Introduction: Varicocele is a condition in which the veins in the spermatic cord become enlarged and twisted. Varicocele is widely recognized as the leading cause of male infertility due to its significant impact on reproductive health in men. The aim of this study was to investigate the relationship between the diameter of the varicose vein and the recovery rate of the spermogram after varicocelectomy. Also, the effect of body mass index (BMI) on sperm parameters after varicocelectomy.

Methods: This descriptive and analytical cross-sectional study was conducted in Valiasr Hospital's urology clinic in Qaemshahr, Iran from August 2018 to August 2019 and involved 27 men with unilateral left varicocele who met the inclusion criteria for surgical repair. Before the operation, we recorded demographic information, the maximum diameter of varicose veins in the pampiniform plexus, and spermogram results. We repeated semen analysis 3 months after the operation and analyzed the data using Statistical Package for the Social Sciences version 21 software.

Results: Our findings showed that the diameter of the varicose vein before varicocelectomy was not significantly associated with the improvement of main semen parameters after the operation. Furthermore, our study suggested that a lower body mass index might contribute to a greater improvement in sperm motility, as individuals with lower BMI showed more significant improvement.

Discussion: There is a significant inverse relationship between BMI and sperm motility improvement after surgery. Patients with a lower BMI showed greater improvement in sperm motility.

简介精索静脉曲张是指精索内的静脉扩大和扭曲。由于精索静脉曲张对男性生殖健康有重大影响,因此被公认为导致男性不育的主要原因。本研究旨在探讨精索静脉曲张直径与精索静脉曲张切除术后精子图恢复率之间的关系。此外,还研究了精索静脉曲张切除术后体重指数(BMI)对精子参数的影响:这项描述性和分析性横断面研究于 2018 年 8 月至 2019 年 8 月在伊朗盖姆沙尔的 Valiasr 医院泌尿科门诊进行,共有 27 名符合手术修复纳入标准的单侧左侧精索静脉曲张男性参与。手术前,我们记录了人口统计学信息、精索静脉丛最大直径和精子图结果。术后 3 个月,我们再次进行了精液分析,并使用社会科学统计软件包 21 版对数据进行了分析:我们的研究结果表明,精索静脉曲张切除术前精索静脉的直径与术后精液主要参数的改善无明显关系。此外,我们的研究还表明,体重指数越低,精子活力改善越明显,因为体重指数越低的人精子活力改善越明显:讨论:体重指数与术后精子活力改善之间存在明显的反比关系。讨论:体重指数与术后精子活力改善之间存在明显的反比关系,体重指数越低的患者精子活力改善越明显。
{"title":"Semen parameter enhancement after varicocelectomy: Insights into varicose vein diameter and BMI influence: A cross-sectional study.","authors":"Mohammad Kazem Hariri, Mohammad-Bagher Rajabalian, Behzad Narouie, Sina Ahmadaghayi, Ghasem Rostami, Khadijeh Ezoji, Hamidreza Momeni, Negar Radpour","doi":"10.1177/03915603241247290","DOIUrl":"10.1177/03915603241247290","url":null,"abstract":"<p><strong>Introduction: </strong>Varicocele is a condition in which the veins in the spermatic cord become enlarged and twisted. Varicocele is widely recognized as the leading cause of male infertility due to its significant impact on reproductive health in men. The aim of this study was to investigate the relationship between the diameter of the varicose vein and the recovery rate of the spermogram after varicocelectomy. Also, the effect of body mass index (BMI) on sperm parameters after varicocelectomy.</p><p><strong>Methods: </strong>This descriptive and analytical cross-sectional study was conducted in Valiasr Hospital's urology clinic in Qaemshahr, Iran from August 2018 to August 2019 and involved 27 men with unilateral left varicocele who met the inclusion criteria for surgical repair. Before the operation, we recorded demographic information, the maximum diameter of varicose veins in the pampiniform plexus, and spermogram results. We repeated semen analysis 3 months after the operation and analyzed the data using Statistical Package for the Social Sciences version 21 software.</p><p><strong>Results: </strong>Our findings showed that the diameter of the varicose vein before varicocelectomy was not significantly associated with the improvement of main semen parameters after the operation. Furthermore, our study suggested that a lower body mass index might contribute to a greater improvement in sperm motility, as individuals with lower BMI showed more significant improvement.</p><p><strong>Discussion: </strong>There is a significant inverse relationship between BMI and sperm motility improvement after surgery. Patients with a lower BMI showed greater improvement in sperm motility.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"794-799"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of antioxidant enzyme levels, oxidative stress markers and serum prolidase activity in testicular cancer. 评估睾丸癌的抗氧化酶水平、氧化应激标记物和血清增殖酶活性。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-05-14 DOI: 10.1177/03915603241249232
Mehmet Kaba, Sinan Kılıç, Halit Demir

Introduction: Testicular cancer is a significant malignancy affecting males, and understanding the underlying biochemical changes associated with the disease is essential for improved management and treatment strategies. Prolidase enzyme, has been implicated in various disease processes. The assessment of serum prolidase activity and its relationship with testicular cancer can provide valuable insights into the pathophysiology of the disease. The objective of this study was to investigate serum prolidase activity, oxidative stress markers, and antioxidant enzyme levels in patients with testicular cancer and evaluate their potential associations, aiming to enhance our understanding of the biochemical alterations and potential implications for testicular cancer management.

Methods: A total of 33 male patients diagnosed with testicular cancer were included, along with 35 age-matched male volunteers as the control group. Serum samples were collected and stored at -20°C until analysis. The measurement of superoxide dismutase (SOD), glutathione peroxidase (GSHPx), glutathione-S-transferase (GST), malondialdehyde (MDA), glutathione (GSH), and prolidase levels was performed.

Results: The findings demonstrated significantly elevated serum prolidase activity and malondialdehyde (MDA) levels in testicular cancer patients compared to the control group (all, p < 0.05). Conversely, superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and glutathione-S-transferase (GST) levels were significantly lower in testicular cancer patients (p < 0.05).

Conclusion: In this study, serum prolidase activity and biochemical markers associated with oxidative stress were investigated in testicular cancer patients. Oxidative stress markers and serum prolidase activity were found to be elevated in testicular cancer. Long-term prospective studies are needed to determine the effectiveness of antioxidant use in cancer treatment.

简介睾丸癌是影响男性的重要恶性肿瘤,了解与该疾病相关的潜在生化变化对于改善管理和治疗策略至关重要。脯氨酸酶与多种疾病过程有关。评估血清丙烯酰酶活性及其与睾丸癌的关系可为了解该疾病的病理生理学提供有价值的信息。本研究旨在调查睾丸癌患者的血清绒毛膜促性腺激素酶活性、氧化应激标记物和抗氧化酶水平,并评估它们之间的潜在关联,从而加深我们对睾丸癌生化改变及其潜在影响的理解:方法:共纳入 33 名确诊为睾丸癌的男性患者,以及 35 名年龄匹配的男性志愿者作为对照组。采集血清样本并保存在零下 20 摄氏度的环境中,直至进行分析。对超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSHPx)、谷胱甘肽-S-转移酶(GST)、丙二醛(MDA)、谷胱甘肽(GSH)和绒毛膜促性腺激素酶水平进行了测定:结果:研究结果表明,与对照组相比,睾丸癌患者血清中的增殖酶活性和丙二醛(MDA)水平明显升高(均为 p p 结论:睾丸癌患者血清中的增殖酶活性和丙二醛(MDA)水平明显升高:本研究调查了睾丸癌患者的血清绒毛膜促性腺激素活性和与氧化应激相关的生化指标。结果发现,睾丸癌患者的氧化应激标记物和血清脯氨酸酶活性升高。需要进行长期的前瞻性研究,以确定抗氧化剂在癌症治疗中的应用效果。
{"title":"Evaluation of antioxidant enzyme levels, oxidative stress markers and serum prolidase activity in testicular cancer.","authors":"Mehmet Kaba, Sinan Kılıç, Halit Demir","doi":"10.1177/03915603241249232","DOIUrl":"10.1177/03915603241249232","url":null,"abstract":"<p><strong>Introduction: </strong>Testicular cancer is a significant malignancy affecting males, and understanding the underlying biochemical changes associated with the disease is essential for improved management and treatment strategies. Prolidase enzyme, has been implicated in various disease processes. The assessment of serum prolidase activity and its relationship with testicular cancer can provide valuable insights into the pathophysiology of the disease. The objective of this study was to investigate serum prolidase activity, oxidative stress markers, and antioxidant enzyme levels in patients with testicular cancer and evaluate their potential associations, aiming to enhance our understanding of the biochemical alterations and potential implications for testicular cancer management.</p><p><strong>Methods: </strong>A total of 33 male patients diagnosed with testicular cancer were included, along with 35 age-matched male volunteers as the control group. Serum samples were collected and stored at -20°C until analysis. The measurement of superoxide dismutase (SOD), glutathione peroxidase (GSHPx), glutathione-S-transferase (GST), malondialdehyde (MDA), glutathione (GSH), and prolidase levels was performed.</p><p><strong>Results: </strong>The findings demonstrated significantly elevated serum prolidase activity and malondialdehyde (MDA) levels in testicular cancer patients compared to the control group (all, <i>p</i> < 0.05). Conversely, superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and glutathione-S-transferase (GST) levels were significantly lower in testicular cancer patients (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>In this study, serum prolidase activity and biochemical markers associated with oxidative stress were investigated in testicular cancer patients. Oxidative stress markers and serum prolidase activity were found to be elevated in testicular cancer. Long-term prospective studies are needed to determine the effectiveness of antioxidant use in cancer treatment.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"807-812"},"PeriodicalIF":0.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologia Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1